Moreover, it was reported that mesothelin-redirected CCL19-IL-7 CAR-Ts mediated meaningful suppression of tumor outgrowth in mice PDX models of mesothelin-expressing pancreatic cancers as compared with conventional CAR-Ts (155). The gene discussed is CCL19; the disease is neoplasm.